| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 20 |
| NetGPI | no | yes: 0, no: 20 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 2 |
| GO:0000331 | contractile vacuole | 6 | 1 |
| GO:0005773 | vacuole | 5 | 1 |
| GO:0031410 | cytoplasmic vesicle | 6 | 1 |
| GO:0031982 | vesicle | 4 | 1 |
| GO:0043226 | organelle | 2 | 1 |
| GO:0043227 | membrane-bounded organelle | 3 | 1 |
| GO:0043229 | intracellular organelle | 3 | 1 |
| GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
| GO:0097708 | intracellular vesicle | 5 | 1 |
Related structures:
AlphaFold database: Q4Q0F2
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0043085 | positive regulation of catalytic activity | 4 | 3 |
| GO:0043087 | regulation of GTPase activity | 5 | 3 |
| GO:0043547 | positive regulation of GTPase activity | 6 | 3 |
| GO:0044093 | positive regulation of molecular function | 3 | 3 |
| GO:0050790 | regulation of catalytic activity | 3 | 3 |
| GO:0051336 | regulation of hydrolase activity | 4 | 3 |
| GO:0051345 | positive regulation of hydrolase activity | 5 | 3 |
| GO:0065007 | biological regulation | 1 | 3 |
| GO:0065009 | regulation of molecular function | 2 | 3 |
| GO:0090630 | activation of GTPase activity | 7 | 3 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005096 | GTPase activator activity | 4 | 3 |
| GO:0008047 | enzyme activator activity | 3 | 3 |
| GO:0030234 | enzyme regulator activity | 2 | 3 |
| GO:0030695 | GTPase regulator activity | 4 | 3 |
| GO:0060589 | nucleoside-triphosphatase regulator activity | 3 | 3 |
| GO:0098772 | molecular function regulator activity | 1 | 3 |
| GO:0140677 | molecular function activator activity | 2 | 3 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 115 | 117 | PF00675 | 0.496 |
| CLV_NRD_NRD_1 | 13 | 15 | PF00675 | 0.574 |
| CLV_NRD_NRD_1 | 148 | 150 | PF00675 | 0.411 |
| CLV_NRD_NRD_1 | 220 | 222 | PF00675 | 0.231 |
| CLV_NRD_NRD_1 | 361 | 363 | PF00675 | 0.392 |
| CLV_NRD_NRD_1 | 89 | 91 | PF00675 | 0.605 |
| CLV_PCSK_KEX2_1 | 115 | 117 | PF00082 | 0.498 |
| CLV_PCSK_KEX2_1 | 13 | 15 | PF00082 | 0.574 |
| CLV_PCSK_KEX2_1 | 144 | 146 | PF00082 | 0.401 |
| CLV_PCSK_KEX2_1 | 148 | 150 | PF00082 | 0.401 |
| CLV_PCSK_KEX2_1 | 155 | 157 | PF00082 | 0.287 |
| CLV_PCSK_KEX2_1 | 220 | 222 | PF00082 | 0.231 |
| CLV_PCSK_KEX2_1 | 361 | 363 | PF00082 | 0.275 |
| CLV_PCSK_KEX2_1 | 383 | 385 | PF00082 | 0.429 |
| CLV_PCSK_KEX2_1 | 89 | 91 | PF00082 | 0.616 |
| CLV_PCSK_PC1ET2_1 | 144 | 146 | PF00082 | 0.399 |
| CLV_PCSK_PC1ET2_1 | 155 | 157 | PF00082 | 0.344 |
| CLV_PCSK_PC1ET2_1 | 383 | 385 | PF00082 | 0.490 |
| CLV_PCSK_SKI1_1 | 220 | 224 | PF00082 | 0.288 |
| CLV_PCSK_SKI1_1 | 272 | 276 | PF00082 | 0.415 |
| CLV_PCSK_SKI1_1 | 350 | 354 | PF00082 | 0.370 |
| CLV_PCSK_SKI1_1 | 361 | 365 | PF00082 | 0.294 |
| CLV_PCSK_SKI1_1 | 390 | 394 | PF00082 | 0.365 |
| CLV_PCSK_SKI1_1 | 82 | 86 | PF00082 | 0.518 |
| DEG_APCC_DBOX_1 | 349 | 357 | PF00400 | 0.417 |
| DEG_SPOP_SBC_1 | 33 | 37 | PF00917 | 0.718 |
| DEG_SPOP_SBC_1 | 65 | 69 | PF00917 | 0.655 |
| DOC_CKS1_1 | 85 | 90 | PF01111 | 0.431 |
| DOC_MAPK_MEF2A_6 | 170 | 178 | PF00069 | 0.231 |
| DOC_MAPK_MEF2A_6 | 346 | 355 | PF00069 | 0.252 |
| DOC_MAPK_MEF2A_6 | 390 | 397 | PF00069 | 0.399 |
| DOC_MAPK_RevD_3 | 1 | 14 | PF00069 | 0.470 |
| DOC_PP1_RVXF_1 | 392 | 398 | PF00149 | 0.453 |
| DOC_USP7_MATH_1 | 184 | 188 | PF00917 | 0.289 |
| DOC_USP7_MATH_1 | 59 | 63 | PF00917 | 0.720 |
| DOC_USP7_MATH_1 | 65 | 69 | PF00917 | 0.695 |
| DOC_USP7_UBL2_3 | 268 | 272 | PF12436 | 0.250 |
| DOC_USP7_UBL2_3 | 390 | 394 | PF12436 | 0.422 |
| DOC_WW_Pin1_4 | 14 | 19 | PF00397 | 0.779 |
| DOC_WW_Pin1_4 | 55 | 60 | PF00397 | 0.664 |
| DOC_WW_Pin1_4 | 61 | 66 | PF00397 | 0.664 |
| DOC_WW_Pin1_4 | 84 | 89 | PF00397 | 0.682 |
| LIG_14-3-3_CanoR_1 | 179 | 184 | PF00244 | 0.289 |
| LIG_14-3-3_CanoR_1 | 206 | 211 | PF00244 | 0.250 |
| LIG_14-3-3_CanoR_1 | 361 | 367 | PF00244 | 0.491 |
| LIG_14-3-3_CanoR_1 | 396 | 405 | PF00244 | 0.420 |
| LIG_14-3-3_CanoR_1 | 73 | 81 | PF00244 | 0.706 |
| LIG_AP2alpha_1 | 95 | 99 | PF02296 | 0.395 |
| LIG_APCC_ABBA_1 | 3 | 8 | PF00400 | 0.695 |
| LIG_Clathr_ClatBox_1 | 355 | 359 | PF01394 | 0.376 |
| LIG_DCNL_PONY_1 | 1 | 4 | PF03556 | 0.447 |
| LIG_deltaCOP1_diTrp_1 | 126 | 135 | PF00928 | 0.385 |
| LIG_deltaCOP1_diTrp_1 | 253 | 260 | PF00928 | 0.420 |
| LIG_eIF4E_1 | 287 | 293 | PF01652 | 0.260 |
| LIG_FHA_1 | 202 | 208 | PF00498 | 0.346 |
| LIG_FHA_1 | 23 | 29 | PF00498 | 0.781 |
| LIG_FHA_1 | 243 | 249 | PF00498 | 0.335 |
| LIG_FHA_1 | 368 | 374 | PF00498 | 0.444 |
| LIG_FHA_2 | 102 | 108 | PF00498 | 0.484 |
| LIG_FHA_2 | 33 | 39 | PF00498 | 0.570 |
| LIG_FHA_2 | 366 | 372 | PF00498 | 0.505 |
| LIG_GBD_Chelix_1 | 190 | 198 | PF00786 | 0.357 |
| LIG_LIR_Gen_1 | 126 | 136 | PF02991 | 0.420 |
| LIG_LIR_Gen_1 | 255 | 264 | PF02991 | 0.324 |
| LIG_LIR_Gen_1 | 334 | 341 | PF02991 | 0.375 |
| LIG_LIR_Gen_1 | 94 | 103 | PF02991 | 0.540 |
| LIG_LIR_Nem_3 | 133 | 138 | PF02991 | 0.384 |
| LIG_LIR_Nem_3 | 171 | 176 | PF02991 | 0.287 |
| LIG_LIR_Nem_3 | 254 | 260 | PF02991 | 0.302 |
| LIG_LIR_Nem_3 | 278 | 282 | PF02991 | 0.382 |
| LIG_LIR_Nem_3 | 313 | 317 | PF02991 | 0.328 |
| LIG_LIR_Nem_3 | 334 | 340 | PF02991 | 0.339 |
| LIG_LIR_Nem_3 | 343 | 348 | PF02991 | 0.319 |
| LIG_LIR_Nem_3 | 97 | 102 | PF02991 | 0.386 |
| LIG_NRBOX | 218 | 224 | PF00104 | 0.172 |
| LIG_PAM2_1 | 310 | 322 | PF00658 | 0.324 |
| LIG_PCNA_PIPBox_1 | 297 | 306 | PF02747 | 0.417 |
| LIG_PCNA_yPIPBox_3 | 211 | 223 | PF02747 | 0.358 |
| LIG_Pex14_1 | 337 | 341 | PF04695 | 0.339 |
| LIG_Pex14_1 | 345 | 349 | PF04695 | 0.304 |
| LIG_Pex14_2 | 275 | 279 | PF04695 | 0.378 |
| LIG_Pex14_2 | 320 | 324 | PF04695 | 0.304 |
| LIG_Pex14_2 | 341 | 345 | PF04695 | 0.389 |
| LIG_Pex14_2 | 95 | 99 | PF04695 | 0.376 |
| LIG_PTB_Apo_2 | 263 | 270 | PF02174 | 0.411 |
| LIG_PTB_Phospho_1 | 263 | 269 | PF10480 | 0.411 |
| LIG_SH2_CRK | 177 | 181 | PF00017 | 0.273 |
| LIG_SH2_GRB2like | 226 | 229 | PF00017 | 0.286 |
| LIG_SH2_GRB2like | 401 | 404 | PF00017 | 0.308 |
| LIG_SH2_NCK_1 | 120 | 124 | PF00017 | 0.360 |
| LIG_SH2_STAP1 | 120 | 124 | PF00017 | 0.360 |
| LIG_SH2_STAP1 | 315 | 319 | PF00017 | 0.267 |
| LIG_SH2_STAT3 | 401 | 404 | PF00017 | 0.450 |
| LIG_SH2_STAT5 | 124 | 127 | PF00017 | 0.431 |
| LIG_SH2_STAT5 | 146 | 149 | PF00017 | 0.537 |
| LIG_SH2_STAT5 | 235 | 238 | PF00017 | 0.302 |
| LIG_SH2_STAT5 | 287 | 290 | PF00017 | 0.381 |
| LIG_SH3_3 | 148 | 154 | PF00018 | 0.504 |
| LIG_SH3_3 | 271 | 277 | PF00018 | 0.305 |
| LIG_SH3_3 | 306 | 312 | PF00018 | 0.192 |
| LIG_SUMO_SIM_anti_2 | 368 | 377 | PF11976 | 0.493 |
| LIG_SUMO_SIM_par_1 | 362 | 371 | PF11976 | 0.463 |
| LIG_TRAF2_1 | 104 | 107 | PF00917 | 0.457 |
| LIG_TRAF2_1 | 36 | 39 | PF00917 | 0.570 |
| LIG_UBA3_1 | 372 | 377 | PF00899 | 0.437 |
| MOD_CDK_SPK_2 | 84 | 89 | PF00069 | 0.420 |
| MOD_CDK_SPxK_1 | 84 | 90 | PF00069 | 0.670 |
| MOD_CK1_1 | 17 | 23 | PF00069 | 0.668 |
| MOD_CK1_1 | 209 | 215 | PF00069 | 0.461 |
| MOD_CK1_1 | 365 | 371 | PF00069 | 0.361 |
| MOD_CK1_1 | 58 | 64 | PF00069 | 0.726 |
| MOD_CK2_1 | 101 | 107 | PF00069 | 0.447 |
| MOD_CK2_1 | 32 | 38 | PF00069 | 0.570 |
| MOD_CK2_1 | 365 | 371 | PF00069 | 0.419 |
| MOD_GlcNHglycan | 211 | 214 | PF01048 | 0.289 |
| MOD_GlcNHglycan | 398 | 401 | PF01048 | 0.540 |
| MOD_GlcNHglycan | 61 | 64 | PF01048 | 0.700 |
| MOD_GlcNHglycan | 77 | 80 | PF01048 | 0.627 |
| MOD_GSK3_1 | 13 | 20 | PF00069 | 0.697 |
| MOD_GSK3_1 | 55 | 62 | PF00069 | 0.707 |
| MOD_NEK2_1 | 163 | 168 | PF00069 | 0.313 |
| MOD_NEK2_1 | 198 | 203 | PF00069 | 0.329 |
| MOD_NEK2_1 | 242 | 247 | PF00069 | 0.323 |
| MOD_NEK2_1 | 388 | 393 | PF00069 | 0.433 |
| MOD_NEK2_1 | 74 | 79 | PF00069 | 0.714 |
| MOD_NEK2_2 | 319 | 324 | PF00069 | 0.311 |
| MOD_PIKK_1 | 179 | 185 | PF00454 | 0.345 |
| MOD_PIKK_1 | 42 | 48 | PF00454 | 0.713 |
| MOD_PK_1 | 206 | 212 | PF00069 | 0.231 |
| MOD_PKA_1 | 13 | 19 | PF00069 | 0.572 |
| MOD_PKA_2 | 13 | 19 | PF00069 | 0.779 |
| MOD_Plk_1 | 198 | 204 | PF00069 | 0.250 |
| MOD_Plk_2-3 | 34 | 40 | PF00069 | 0.574 |
| MOD_Plk_4 | 242 | 248 | PF00069 | 0.305 |
| MOD_Plk_4 | 310 | 316 | PF00069 | 0.310 |
| MOD_Plk_4 | 319 | 325 | PF00069 | 0.311 |
| MOD_ProDKin_1 | 14 | 20 | PF00069 | 0.780 |
| MOD_ProDKin_1 | 55 | 61 | PF00069 | 0.665 |
| MOD_ProDKin_1 | 84 | 90 | PF00069 | 0.679 |
| MOD_SUMO_for_1 | 356 | 359 | PF00179 | 0.327 |
| MOD_SUMO_rev_2 | 105 | 110 | PF00179 | 0.553 |
| MOD_SUMO_rev_2 | 182 | 190 | PF00179 | 0.429 |
| TRG_DiLeu_BaEn_1 | 359 | 364 | PF01217 | 0.321 |
| TRG_DiLeu_BaEn_4 | 359 | 365 | PF01217 | 0.335 |
| TRG_DiLeu_BaLyEn_6 | 218 | 223 | PF01217 | 0.172 |
| TRG_DiLeu_LyEn_5 | 359 | 364 | PF01217 | 0.321 |
| TRG_ENDOCYTIC_2 | 177 | 180 | PF00928 | 0.307 |
| TRG_ENDOCYTIC_2 | 301 | 304 | PF00928 | 0.298 |
| TRG_ER_diArg_1 | 12 | 14 | PF00400 | 0.572 |
| TRG_ER_diArg_1 | 219 | 221 | PF00400 | 0.231 |
| TRG_ER_diArg_1 | 361 | 363 | PF00400 | 0.353 |
| TRG_ER_diArg_1 | 88 | 90 | PF00400 | 0.633 |
| TRG_NES_CRM1_1 | 237 | 252 | PF08389 | 0.321 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1I3T4 | Leptomonas seymouri | 58% | 96% |
| A0A0N1PDX9 | Leptomonas seymouri | 36% | 75% |
| A0A0S4II34 | Bodo saltans | 36% | 97% |
| A0A0S4ITU5 | Bodo saltans | 26% | 100% |
| A0A1X0NLM2 | Trypanosomatidae | 43% | 100% |
| A0A1X0NLQ9 | Trypanosomatidae | 44% | 97% |
| A0A1X0P1K5 | Trypanosomatidae | 27% | 100% |
| A0A3S7X3S6 | Leishmania donovani | 25% | 100% |
| A0A3S7XBZ8 | Leishmania donovani | 93% | 100% |
| A0A3S7XC15 | Leishmania donovani | 35% | 83% |
| A0A422NJ84 | Trypanosoma rangeli | 42% | 99% |
| A0A422NJE8 | Trypanosoma rangeli | 40% | 100% |
| A4HIL7 | Leishmania braziliensis | 23% | 100% |
| A4HQC6 | Leishmania braziliensis | 38% | 84% |
| A4HQC7 | Leishmania braziliensis | 71% | 97% |
| A4I5W2 | Leishmania infantum | 24% | 100% |
| A4IE19 | Leishmania infantum | 35% | 83% |
| A4IE20 | Leishmania infantum | 93% | 100% |
| D0A3X5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 100% |
| D0A3X9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 99% |
| E9AU42 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 42% | 74% |
| E9AU43 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
| E9B157 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 100% |
| Q09445 | Caenorhabditis elegans | 26% | 100% |
| Q12317 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 28% | 84% |
| Q4Q0F3 | Leishmania major | 42% | 83% |
| V5BDT8 | Trypanosoma cruzi | 27% | 74% |
| V5BT66 | Trypanosoma cruzi | 43% | 100% |